Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.

Department of Medicine, Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
PLoS Pathogens (Impact Factor: 8.06). 07/2009; 5(6):e1000480. DOI: 10.1371/journal.ppat.1000480
Source: PubMed

ABSTRACT Modified vaccinia virus Ankara (MVA) is an attenuated double-stranded DNA poxvirus currently developed as a vaccine vector against HIV/AIDS. Profiling of the innate immune responses induced by MVA is essential for the design of vaccine vectors and for anticipating potential adverse interactions between naturally acquired and vaccine-induced immune responses. Here we report on innate immune sensing of MVA and cytokine responses in human THP-1 cells, primary human macrophages and mouse bone marrow-derived macrophages (BMDMs). The innate immune responses elicited by MVA in human macrophages were characterized by a robust chemokine production and a fairly weak pro-inflammatory cytokine response. Analyses of the cytokine production profile of macrophages isolated from knockout mice deficient in Toll-like receptors (TLRs) or in the adapter molecules MyD88 and TRIF revealed a critical role for TLR2, TLR6 and MyD88 in the production of IFNbeta-independent chemokines. MVA induced a marked up-regulation of the expression of RIG-I like receptors (RLR) and the IPS-1 adapter (also known as Cardif, MAVS or VISA). Reduced expression of RIG-I, MDA-5 and IPS-1 by shRNAs indicated that sensing of MVA by RLR and production of IFNbeta and IFNbeta-dependent chemokines was controlled by the MDA-5 and IPS-1 pathway in the macrophage. Crosstalk between TLR2-MyD88 and the NALP3 inflammasome was essential for expression and processing of IL-1beta. Transcription of the Il1b gene was markedly impaired in TLR2(-/-) and MyD88(-/-) BMDM, whereas mature and secreted IL-1beta was massively reduced in NALP3(-/-) BMDMs or in human THP-1 macrophages with reduced expression of NALP3, ASC or caspase-1 by shRNAs. Innate immune sensing of MVA and production of chemokines, IFNbeta and IL-1beta by macrophages is mediated by the TLR2-TLR6-MyD88, MDA-5-IPS-1 and NALP3 inflammasome pathways. Delineation of the host response induced by MVA is critical for improving our understanding of poxvirus antiviral escape mechanisms and for designing new MVA vaccine vectors with improved immunogenicity.

Download full-text


Available from: Carmen Elena Gomez, Jul 30, 2015
  • Source
    • "(Adamo et al., 2004) and that the two adaptor molecules MyD88 and TRIF divide TLR signaling pathways. Furthermore, caspase recruitment domain adaptorinducing interferon- (Cardif) is a crucial adaptor molecule in the signaling cascade of RIG-I–like receptors in antiviral responses such as against MVA (Delaloye et al., 2009). We therefore attempted to induce BALT in mice deficient for one (Myd88 / , Trif / , or Cardif / ) or two (Myd88 / Trif / ) of these adaptors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ectopic lymphoid tissue, such as bronchus-associated lymphoid tissue (BALT) in the lung, develops spontaneously at sites of chronic inflammation or during infection. The molecular mechanisms underlying the neogenesis of such tertiary lymphoid tissue are still poorly understood. We show that the type of inflammation-inducing pathogen determines which key factors are required for the formation and maturation of BALT. Thus, a single intranasal administration of the poxvirus modified vaccinia virus Ankara (MVA) is sufficient to induce highly organized BALT with densely packed B cell follicles containing a network of CXCL13-expressing follicular DCs (FDCs), as well as CXCL12-producing follicular stromal cells. In contrast, mice treated with P. aeruginosa (P.a.) develop BALT but B cell follicles lack FDCs while still harboring CXCL12-positive follicular stromal cells. Furthermore, in IL-17-deficient mice, P.a.-induced BALT largely lacks B cells as well as CXCL12-expressing stromal cells, and only loose infiltrates of T cells are present. We show that Toll-like receptor pathways are required for BALT induction by P.a., but not MVA, and provide evidence that IL-17 drives the differentiation of lung stroma toward podoplanin-positive CXCL12-expressing cells that allow follicle formation even in the absence of FDCs. Taken together, our results identify distinct pathogen-dependent induction and maturation pathways for BALT formation.
    Journal of Experimental Medicine 03/2014; 211(4). DOI:10.1084/jem.20131737 · 13.91 Impact Factor
  • Source
    • "While a distinct role for AIM2 as a major receptor for pathogenic DNA and activation of the inflammasome has emerged (Rathinam et al., 2010), it has been demonstrated that NLRP3 plays a minor but definite role in response to certain viruses. NLRP3 is necessary for caspase-1 activation in response to adenoviral DNA, herpes simplex virus and modified vaccinia virus (Muruve et al., 2008; Delaloye et al., 2009). Double stranded- RNA from influenza and sendai virus can also stimulate the NLRP3 inflammasome with a prominent requirement for NLRP3 particularly at high doses of virus i.e. influenza A (Ichinohe et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The extensively studied cytokine IL-1β is an important mediator of the inflammatory response. However, dysregulated release of IL-1β can be detrimental and is attributed to the progression and pathogenesis of multiple inflammatory diseases including, rhuematoid arthritis (RA), atherosclerosis, type 2 diabetes (T2D), Alzheimers disease and gout. IL-1β is encoded as a pro-protein. A multi-protein molecular scaffold termed the "Inflammasome" is responsible for the tightly controlled and coordinated processing of pro-IL-1β. The activation of several NLR (nucleotide-binding oligomerization domain (NOD)-like receptor) family members and PYHIN (pyrin and HIN domain) proteins can drive the formation of inflammasomes. However, the exact biochemical mechanisms governing their activation have been the subject of much research. Different inflammasomes have been demonstrated to respond to the same pathogen inducing a cooperative immune response accountable for the clearance of infection. Here, we review current knowledge surrounding the biochemical regulation of the NLRP1, NLRP3, NLRC4, AIM2 and IFI16 inflammasomes.
    Critical Reviews in Biochemistry and Molecular Biology 06/2012; 47(5):424-43. DOI:10.3109/10409238.2012.694844 · 5.81 Impact Factor
  • Source
    • "Particularly interesting is the use of oncolytic poxvirus vectors, such as attenuated vaccinia strains. These viruses have a large genome with a high cloning capacity, they can infect practically any mammalian cell type leading to TLR activation, and they hold great promises for the treatment of cancer and infectious diseases such as malaria or HIV-1 [157] [158] [159] [160] [161]. Nevertheless, a substantive effort is being invested in the improvement of retroviral/lentiviral design to circumvent their genotoxic effects. "
    [Show abstract] [Hide abstract]
    ABSTRACT: One of the major challenges in achieving effective anti-cancer immunotherapy is to counteract immunological tolerance. Most tumor-associated antigens (TAAs) are sensed as self. Hence, naturally occurring tolerance towards them has to be overcome. Fortunately, there is increasing evidence that anti-tumor immune responses occur and play a crucial role in the success of well-established anti-neoplastic therapies such as radiotherapy and chemotherapy. In fact, their effectiveness relies on signalling by pattern recognition receptors such as Toll-like receptors (TLRs). TLR signal transduction involves activation of a few well-known pathways, of which nuclear factor κB (NF-κB) and mitogen activated protein kinases (MAPKs) are possibly the best characterized. Therefore, constitutive activation of these pathways in immune cells can potentially enhance anti-tumor immunity, especially when targeted to professional antigen presenting cells (APCs) such as dendritic cells (DCs). Several strategies have been devised to test this hypothesis, including constitutive activation of TLRs, NF-κB and MAPKs (extracellular-signal regulated kinase (ERK), p38 and c-Jun kinase 1 (JNK1)). Activation of these pathways in mouse and human DCs has differential effects in immunogenicity and in many cases, enhanced antitumor immunity in pre-clinical models, establishing the basis for future clinical applications.
    Anti-cancer agents in medicinal chemistry 06/2011; 12(1):29-39. DOI:10.2174/187152012798764679 · 2.94 Impact Factor
Show more